QIM
Quantitative Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,677
| Closed | -$134K | – | 220 |
|
|
2022
Q3 | $134K | Buy |
+10,677
| New | +$134K | 0.02% | 264 |
|
|
2022
Q2 | – | Sell |
-21,035
| Closed | -$342K | – | 217 |
|
|
2022
Q1 | $342K | Buy |
+21,035
| New | +$342K | 0.04% | 160 |
|
|
2021
Q1 | – | Sell |
-256,210
| Closed | -$1.91M | – | 501 |
|
|
2020
Q4 | $1.91M | Buy |
+256,210
| New | +$1.91M | 0.15% | 155 |
|
|
2020
Q3 | – | Sell |
-77,301
| Closed | -$368K | – | 403 |
|
|
2020
Q2 | $368K | Buy |
+77,301
| New | +$368K | 0.04% | 387 |
|
|
2020
Q1 | – | Sell |
-24,704
| Closed | -$85K | – | 522 |
|
|
2019
Q4 | $85K | Sell |
24,704
-4,245
| -15% | -$14.6K | ﹤0.01% | 605 |
|
|
2019
Q3 | $82K | Buy |
+28,949
| New | +$82K | ﹤0.01% | 569 |
|
|
2019
Q1 | – | Sell |
-23,800
| Closed | -$192K | – | 650 |
|
|
2018
Q4 | $192K | Buy |
+23,800
| New | +$192K | 0.01% | 497 |
|
|
2018
Q3 | – | Sell |
-74,800
| Closed | -$428K | – | 644 |
|
|
2018
Q2 | $428K | Buy |
+74,800
| New | +$428K | 0.01% | 624 |
|
|
2016
Q2 | – | Sell |
-103,800
| Closed | -$293K | – | 743 |
|
|
2016
Q1 | $293K | Buy |
+103,800
| New | +$293K | 0.01% | 639 |
|
|
2015
Q4 | – | Sell |
-19,100
| Closed | -$217K | – | 689 |
|
|
2015
Q3 | $217K | Buy |
19,100
+1,800
| +10% | +$20.5K | 0.02% | 596 |
|
|
2015
Q2 | $258K | Buy |
+17,300
| New | +$258K | 0.04% | 344 |
|
|
2014
Q2 | – | Sell |
-11,500
| Closed | -$121K | – | 467 |
|
|
2014
Q1 | $121K | Buy |
+11,500
| New | +$121K | 0.01% | 498 |
|